NIH-funded research U01 cooperative agreement

Understanding brain markers of PTSD, depression, and anxiety across large imaging datasets

Official title: Understanding Heterogeneity Across PTSD, MDD and Anxiety By Leveraging Large-scale Multimodal Neuroimaging Datasets

Funded at University of Texas Arlington · NIH-11376509 · Data updated 2026-11-12

A large study will look at brain scans from people with PTSD, depression, and anxiety to find brain patterns that are linked to these conditions and to see how they relate to symptoms and treatment outcomes.

More Anxiety research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Texas Arlington
NIH-funded
Lab location1 site (Arlington, United States)
Project startJuly 21, 2025
Project endApril 30, 2030
Funding year2026
Award (this year)$638,574
NIH project number5U01MH138425-02
Project IDNIH-11376509 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with PTSD, major depressive disorder, or anxiety disorders who have imaging data available or can be recruited for imaging studies.

Less likely to help

People without PTSD, MDD, or anxiety disorders or those unable to undergo MRI may not benefit.

What this research studies

This project uses big clinical and brain-imaging data from diverse populations to find neural biomarkers that explain why PTSD, depression, and anxiety often occur together. It will apply both a top-down framework (RDoC) and bottom-up data-driven methods to identify distinct and shared brain-based biotypes. By analyzing structural MRI and resting-state fMRI from four global datasets, researchers aim to improve understanding of how these disorders differ and overlap. The goal is to move toward personalized medicine that can guide more precise prevention and treatment strategies.

Why it matters

Potential benefit: If successful, patients could experience more accurate diagnoses and personalized treatments based on brain biomarkers.

How similar studies have gone: Previous studies have shown meaningful brain-imaging biomarkers for psychiatric conditions, though this study emphasizes cross-disorder biotypes and explainable AI.

Where this research is happening

  • University of Texas Arlington
    Arlington, United States
    Active

Researchers

  • Principal investigator: Zhu, Xi — University of Texas Arlington
  • Study coordinator: Zhu, Xi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.